Aim Evidence
The aim of these guidelines is to assist midwives and doctors to detect syphilis in pregnant women in order to treat mothers and prevent transmission to infants.
Syphilis has significant long-term morbidity for mothers and can seriously complicate pregnancy, resulting in spontaneous abortion, stillbirth, nonimmune hydrops, intrauterine growth restriction, malformations and perinatal death. Congenital syphilis results in serious sequelae in liveborn infected children. Screening pregnant women for syphilis and treating them appropriately can eliminate complications .
The evidence available (Level III and IV) indicates that screening for syphilis should be part of routine antenatal care. Universal screening programs have been shown to significantly increase the detection of pregnant women who have syphilis compared with selective screening of women considered to be a highrisk . Research from the UK indicates that women from a non-white ethnic group and born outside the UK have a strong risk of syphilis, but a significant number of cases are missed even if selective screening based on these risk factors is in place . Universal screening for syphilis has been shown cost-effective even in areas of low prevalence .
Syphilis screening should be undertaken at the first antenatal visit, ideally prior to the sixteenth week of pregnancy . In populations of high prevalence the test should be repeated during the third trimester or at the time of delivery . It has also been suggested that there should be universal repeat screening for syphilis in the third trimester . 4. When, how and by whom should syphilis testing be offered to women?
The search retrieved 94 citations and 24 key citations were identified for appraisal. These included three Level III-2 studies, 19 Level IV studies/documents and two letters.
The team did not identify research investigating who should offer this screening test to pregnant women or the manner in which it should be offered. 
